Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA ALEMBIC PHARMA GLENMARK PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x -31.4 32.2 - View Chart
P/BV x 2.9 4.4 64.7% View Chart
Dividend Yield % 0.3 0.8 32.1%  

Financials

 GLENMARK PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
ALEMBIC PHARMA
Mar-23
GLENMARK PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs487792 61.5%   
Low Rs349463 75.3%   
Sales per share (Unadj.) Rs460.4287.6 160.1%  
Earnings per share (Unadj.) Rs13.417.4 76.9%  
Cash flow per share (Unadj.) Rs35.031.4 111.5%  
Dividends per share (Unadj.) Rs2.508.00 31.3%  
Avg Dividend yield %0.61.3 46.9%  
Book value per share (Unadj.) Rs335.1222.3 150.7%  
Shares outstanding (eoy) m282.17196.56 143.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.92.2 41.6%   
Avg P/E ratio x31.336.1 86.6%  
P/CF ratio (eoy) x11.920.0 59.7%  
Price / Book Value ratio x1.22.8 44.2%  
Dividend payout %18.746.0 40.7%   
Avg Mkt Cap Rs m117,953123,402 95.6%   
No. of employees `000NANA-   
Total wages/salary Rs m27,81011,691 237.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m129,90156,526 229.8%  
Other income Rs m3,16830 10,420.6%   
Total revenues Rs m133,06956,557 235.3%   
Gross profit Rs m15,1256,772 223.4%  
Depreciation Rs m6,1132,754 221.9%   
Interest Rs m3,496502 696.8%   
Profit before tax Rs m8,6853,546 244.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,911126 3,894.1%   
Profit after tax Rs m3,7743,420 110.4%  
Gross profit margin %11.612.0 97.2%  
Effective tax rate %56.53.6 1,590.0%   
Net profit margin %2.96.1 48.0%  
BALANCE SHEET DATA
Current assets Rs m98,73729,139 338.9%   
Current liabilities Rs m50,45516,408 307.5%   
Net working cap to sales %37.222.5 165.0%  
Current ratio x2.01.8 110.2%  
Inventory Days Days710 69.1%  
Debtors Days Days1157 1,704.4%  
Net fixed assets Rs m76,92031,498 244.2%   
Share capital Rs m282393 71.8%   
"Free" reserves Rs m94,28143,312 217.7%   
Net worth Rs m94,56343,705 216.4%   
Long term debt Rs m38,5210-   
Total assets Rs m175,65860,637 289.7%  
Interest coverage x3.58.1 43.2%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.70.9 79.3%   
Return on assets %4.16.5 64.0%  
Return on equity %4.07.8 51.0%  
Return on capital %9.29.3 98.8%  
Exports to sales %046.4 0.0%   
Imports to sales %012.1 0.0%   
Exports (fob) Rs mNA26,210 0.0%   
Imports (cif) Rs mNA6,846 0.0%   
Fx inflow Rs m46,46426,210 177.3%   
Fx outflow Rs m12,7126,846 185.7%   
Net fx Rs m33,75119,364 174.3%   
CASH FLOW
From Operations Rs m6,2547,240 86.4%  
From Investments Rs m-5,285-4,476 118.1%  
From Financial Activity Rs m-775-2,620 29.6%  
Net Cashflow Rs m325144 225.9%  

Share Holding

Indian Promoters % 46.7 69.1 67.5%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 34.7 19.0 182.3%  
FIIs % 23.7 4.5 524.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 30.4 175.6%  
Shareholders   209,931 85,212 246.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Glenmark Pharma vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Glenmark Pharma vs ALEMBIC PHARMA Share Price Performance

Period Glenmark Pharma ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day -0.57% -0.15% 1.18%
1-Month 5.16% -4.30% -0.75%
1-Year 112.94% 105.43% 61.82%
3-Year CAGR 27.51% 0.89% 18.16%
5-Year CAGR 8.05% 13.56% 19.79%

* Compound Annual Growth Rate

Here are more details on the Glenmark Pharma share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of Glenmark Pharma hold a 46.7% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Glenmark Pharma and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, Glenmark Pharma paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 18.7%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of Glenmark Pharma, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.